Merck & Co Option Alert: Jan, 2027 $100 Puts Sweep (4) near the Bid: 560 vs 1142 OI; Earnings 10/30 Before Open 

Merck & Co Option Alert: Jan, 2027 $100 Puts Sweep (4) near the Bid: 560 @ $16.23 vs 1142 OI; Earnings 10/30 Before Open Ref=$89.8

Merck & Co Option Alert: Jan 16 $100 Calls at the Bid: 3000 vs 12858 OI; Earnings 10/30 Before Open 

Merck & Co Option Alert: Jan 16 $100 Calls at the Bid: 3000 @ $2.14 vs 12858 OI; Earnings 10/30 Before Open Ref=$90.13

Merck & Co Option Alert: Dec, 2027 $90 Calls Sweep (3) near the Bid: 500 vs 1811 OI; Earnings 10/30 Before Open 

Merck & Co Option Alert: Dec, 2027 $90 Calls Sweep (3) near the Bid: 500 @ $13.25 vs 1811 OI; Earnings 10/30 Before Open Ref=$88.5106

Merck & Co Option Alert: Jan 16 $70 Calls at the Bid: 600 vs 668 OI; Earnings 10/30 Before Open [est] 

Merck & Co Option Alert: Jan 16 $70 Calls at the Bid: 600 @ $10.8 vs 668 OI; Earnings 10/30 Before Open [est] Ref=$78.64

Merck & Co Option Alert: Dec 19 $80 Calls Sweep (4) near the Ask: 1441 vs 2412 OI; Earnings 10/30 Before Open [est] 

Merck & Co Option Alert: Dec 19 $80 Calls Sweep (4) near the Ask: 1441 @ $3.8 vs 2412 OI; Earnings 10/30 Before Open [est] Ref=$78.27

Merck & Co

MERCK & CO. INC.

Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform, led by Keytruda, is a major contributor to overall sales. The company also has a substantial vaccine business aimed at preventing pediatric diseases, as well as Gardasil for human papillomavirus. Additionally, Merck sells animal health-related drugs. From a geographical perspective, 47% of the company's sales are generated from US human health (pharmaceuticals and vaccines).

South,San,Francisco,,Ca,,Usa,-,May,1,,2022:,Merck

Long Ideas

News

Dividends

Price Target

Pre-Market Outlook

Markets

Analyst Ratings

Trading Ideas

Gli analisti più accurati di Wall Street puntano su 3 titoli con dividendi fino al 6,7%. Le loro scelte per la difesa del portafoglio.

3 nomi del settore sanitario che pagano generosi dividendi

Pfizer logo on building

ARVN

XRAY

Cerchi rendimenti stabili? Tre titoli nel settore sanitario mostrano un potenziale interessante. Un&#39;analisi approfondita per investitori.

Titoli a dividendo: 3 occasioni nel settore sanitario per il tuo portafoglio

Dividend,Growth,And,Profits,With,Finger,Pointing,On,The,Graph.

SPRO

Questi colossi del settore della salute offrono rendimenti solidi e hanno il sostegno di alcuni dei nomi più affidabili del settore.

3 titoli a dividendo scelti dagli analisti più &#34;precisi&#34; di Wall Street

Merck & Co Inc

Marker Therapeutics Inc

MARKY CORP by MARKY CORP.

Press Releases

CAPVAXIVE® (Pneumococcal 21-valent Conjugate Vaccine) Demonstrates Positive Immune Responses in Children and Adolescents at Increased Risk of Pneumococcal Disease

Raludotatug Deruxtecan Granted Breakthrough Therapy Designation by U.S. FDA for Patients with CDH6 Expressing Platinum-Resistant Ovarian, Primary Peritoneal or Fallopian Tube Cancers Previously Treated with Bevacizumab

Small Cap

Opinion

Advancing Cancer Research Brings New Hope for Patients Worldwide

Merck Receives Two Positive EU CHMP Opinions for KEYTRUDA® (pembrolizumab), for Subcutaneous (SC) Administration and for New Indication for Earlier-Stage Head and Neck Cancer

Merck Receives Positive EU CHMP Opinion for ENFLONSIA™ (clesrovimab) for the Prevention of Respiratory Syncytial Virus (RSV) in Infants During Their First RSV Season

FDA Approves Merck's KEYTRUDA QLEX™ (pembrolizumab and berahyaluronidase alfa-pmph) Injection for Subcutaneous Use in Adults Across Most Solid Tumor Indications for KEYTRUDA® (pembrolizumab)

Shareholders of Verona Pharma Approve Proposed Acquisition by Merck

WINREVAIR™ (sotatercept-csrk) Reduced the Risk of Clinical Worsening Events by 76% Compared to Placebo in Patients Recently Diagnosed With PAH on Background Therapy in Phase 3 HYPERION Trial

Merck to Hold Third-Quarter 2025 Sales and Earnings Conference Call Oct. 30

HEALTH CANADA Approves BRAVECTO® QUANTUM (Fluralaner for Extended-release Injectable Suspension) from Merck Animal Health

IOVA

OTLC

TYO:4568

VRNA

Amneal Pharmaceuticals, Inc. - Class A Common Stock

Amneal Pharmaceuticals

Axsome Therapeutics

AstraZeneca PLC - American Depositary Shares

AstraZeneca

Bristol-Myers Squibb Company Common Stock

Bristol-Myers Squibb

Corcept Therapeutics Incorporated - Common Stock

Corcept Therapeutics

Crinetics Pharmaceuticals, Inc. - Common Stock

Crinetics Pharmaceuticals

Elanco Animal Health Incorporated Common Stock

Elanco Animal Health

GSK plc American Depositary Shares (Each representing two Ordinary Shares)

Haleon plc American Depositary Shares (Each representing two Ordinary Shares)

Haleon

Jazz Pharmaceuticals plc - Ordinary Shares

Jazz Pharmaceuticals

Johnson & Johnson

Ligand Pharmaceuticals Incorporated - Common Stock

Ligand Pharmaceuticals

Eli Lilly

Novo Nordisk

Novartis

Pfizer

Dr. Reddy's Laboratories Ltd Common Stock

Dr Reddy's Laboratories

Regencell Bioscience Holdings Limited - Ordinary Shares

Regencell Bioscience

Royalty Pharma plc - Class A Ordinary Shares

Royalty Pharma

Sanofi

Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)

Takeda Pharmaceutical Co

Teva Pharmaceutical Industries Limited American Depositary Shares

Teva Pharmaceutical Indus

Verona Pharma plc - American Depositary Shares

Verona Pharma

Viatris

Zoetis

Berenberg

Wells Fargo

Morgan Stanley

Citigroup

Cantor Fitzgerald

Screenshot 2025-07-10 at 8.34.03 PM

Biotech

KERX

When it comes to unmet needs in the nephrology space, acute kidney injury remains a significant concern.

SeaStar Medical&#39;s QUELIMMUNE Wins Prestigious Award From The National Kidney Foundation, Former Winners Include Names Like Janssen, Merck and Otsuka

Screenshot 2025-05-21 at 5.43.26 PM

SPACE

Emerging Markets

ASTI

Space Exploration Will Continue Despite NASA Budget Cuts – How Will CIGS-Maker Ascent Solar (ASTI) Be Impacted?

Screenshot 2024-09-30 at 9.13.36 PM

General

TNXP

VRTX

The Rush For Non-Addictive Painkillers To Counter The Opioid Crisis Puts Two Companies Closer To FDA Decisions

Screenshot 2024-09-30 at 5.38.54 PM

Movers & Shakers

COSM

Nestle Sponsored representing Registered Shares Series B

NSRGY

VTRS

How Cosmos Health&#39;s Acquisition Of Almost 100-Year-Old Company, Adding To Capabilities Like Contract Manufacturing, Could Generate Over $10 Million In Annual Gross Profit

Date	Put/Call	Strike Price	Exp Date	DTE	Trade Vol	Day Vol	Vol / OI	OI	Trade Type	Sentiment
02:56 PMOct 03, 2025	PUT	$100.00	Jan 15, 2027	466	575	560	50	1142	SWEEP	BULLISH
01:58 PMOct 03, 2025	CALL	$100.00	Jan 16, 2026	102	3644	3000	28	12858	TRADE	BEARISH
01:09 PMOct 02, 2025	CALL	$90.00	Dec 17, 2027	802	552	500	30	1811	SWEEP	BEARISH
02:10 PMSep 29, 2025	CALL	$70.00	Jan 16, 2026	102	604	600	90	668	TRADE	BULLISH
09:33 AMSep 26, 2025	CALL	$80.00	Dec 19, 2025	74	1444	1441	60	2412	SWEEP	BULLISH

Comments

Merck & Co

Unusual Options Activity for

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO